How much money will my patient be charged for this test?

Patient charges will depend on the patient's specific insurance plan and coverage.  For example, some diagnostic tests may be subject to deductible amounts, co-payments, or co-insurance.... Read more

Does insurance cover this test?

Cernostics bills according to Common Procedural Terminology (CPT) Codes approved by the American Medical Association.  These codes are paid by all payers in the United States, including the Center for Medicaid and Medicare Services, and private insu... Read more

How do I interpret the result of the test?9,10,11

The assay provides physicians and patients with an individualized risk score from 0-10 and risk class (low, intermediate, high) to guide decision-making on surveillance frequency and therapies. The risk score is correlated with a probability of progr... Read more

What information do I need to provide on the test requisition form?

The Requisition shall include the patient's name, date of birth, gender, medical record number, Specimen collection date, ordering physician's first and last name, treating physician's first and last name, initial pathology diagnosis c... Read more

What is turnaround time for obtaining the test results?

We will return a test result to the ordering physician within fourteen business days of receiving the tissue specimens, and a complete test requisition order form.... Read more

How many biopsies can be evaluated from each patient?

Cernostics will evaluate sections from a minimum of one biopsy level from every patient, and can evaluate as many biopsy levels as are obtained during an upper GI endoscopy procedure.  Tissue sections should be provided from the biopsy level with th... Read more

What kind of specimen is needed?

The assay requires preparing nine (9) glass slides with serial tissue sections taken at five (5) micron thickness from formalin-fixed, paraffin-embedded tissue blocks.  These sections cannot have been treated with Bouin's reagent or methylene b... Read more

How does the TissueCypher Barrett's Esophagus Assay compare to standard histopathology?

The TissueCypher™ technology is quantitative and objective, which represents a significant improvement over standard histopathology, which is qualitative and subjective. The deep tissue interrogation provided by TissueCypher™ enables dete... Read more

What is the clinical evidence that supports clinical use of the TissueCypher™ Barrett's Esophagus Assay?9,10,11

Cernostics has completed two multi-institutional independent clinical validation studies on the TissueCypher™ Barrett's Esophagus Assay. The first study demonstrated that the assay can predict future risk of development of HGD or EAC (n=36... Read more

How does this test work?9,10,11

The test evaluates multiple epithelial and stromal processes in Barrett's biopsies to produce an individualized risk score for progression to high grade dysplasia (HGD) or esophageal adenocarcinoma (EAC). The test employs multiplexed fluorescenc... Read more
Customer Service

Mon-Fri 9am-5pm (EST)